Nexalin Technology (NXL) Change in Accured Expenses (2022 - 2025)
Nexalin Technology (NXL) has 4 years of Change in Accured Expenses data on record, last reported at -$47973.0 in Q3 2025.
- For Q3 2025, Change in Accured Expenses fell 708.72% year-over-year to -$47973.0; the TTM value through Sep 2025 reached -$48816.0, up 86.4%, while the annual FY2024 figure was -$110539.0, 32.41% up from the prior year.
- Change in Accured Expenses reached -$47973.0 in Q3 2025 per NXL's latest filing, down from -$21338.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $97322.0 in Q4 2022 and bottomed at -$230747.0 in Q2 2024.
- Average Change in Accured Expenses over 4 years is -$16112.3, with a median of $5973.0 recorded in 2023.
- Peak YoY movement for Change in Accured Expenses: surged 316.82% in 2023, then tumbled 3963.17% in 2024.
- A 4-year view of Change in Accured Expenses shows it stood at $97322.0 in 2022, then crashed by 336.95% to -$230607.0 in 2023, then surged by 107.76% to $17898.0 in 2024, then tumbled by 368.04% to -$47973.0 in 2025.
- Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$47973.0 in Q3 2025, -$21338.0 in Q2 2025, and $2597.0 in Q1 2025.